Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2000
11/09/2000WO2000066586A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000WO2000066585A1 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS
11/09/2000WO2000066584A1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
11/09/2000WO2000066572A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000WO2000066567A1 Pyrimidinone compounds
11/09/2000WO2000066566A1 Pyrimidine compounds
11/09/2000WO2000066563A1 Imidazoline derivatives as alpha-1a adrenoceptor ligands
11/09/2000WO2000066558A1 Piperazine derivatives useful as ccr5 antagonists
11/09/2000WO2000066546A2 Monofluoroalkyl derivatives
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066150A1 New use of a substance in pns
11/09/2000WO2000066148A1 Novel proteins
11/09/2000WO2000066144A2 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections
11/09/2000WO2000066130A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
11/09/2000WO2000066121A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000WO2000066115A1 Device and method for prophylaxis of migraine
11/09/2000WO2000066112A1 Cxcr-4 receptor antagonists - thrombopoietin mimetics
11/09/2000WO2000066110A1 Glycine cleavage system inhibitors as potential antipsychotics
11/09/2000WO2000066109A2 Intravenous valproate for acute treatment of migraine headache
11/09/2000WO2000066108A2 Anticonvulsant derivatives useful in treating cocaine dependency
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000WO2000066102A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000WO2000066082A1 Anti-nausea compositions and methods
11/09/2000WO2000066068A2 Method for inducing growth and enhancing survival of nervous tissue
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000038672A3 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000028981A3 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999045907A9 Metal chelators for use in the treatment of alzheimer's disease
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372806A1 Intravenous valproate for acute treatment of migraine headache
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372790A1 Monthly doses for treatment of streptococcus pneumonia infections
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372490A1 Monofluoroalkyl derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372342A1 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/09/2000CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/09/2000CA2372083A1 Anticonvulsant derivatives useful in treating cocaine dependency
11/09/2000CA2372077A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000CA2372073A1 Glycine cleavage system inhibitors as potential antipsychotics
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2371271A1 9h-pyrimido¬4,5-b|indole derivatives: crf1 specific ligands
11/09/2000CA2371260A1 Materials and methods relating to neuronal development
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365258A1 Heteroaryl diazabicycloalkanes, their preparation and use
11/09/2000CA2335966A1 Method for inducing growth and enhancing survival of nervous tissue
11/08/2000EP1050531A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases
11/08/2000EP1050530A1 1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancers
11/08/2000EP1050309A1 Neurotrophic factor secretion promoters
11/08/2000EP1050307A1 CCR4 antagonists in sepsis
11/08/2000EP1050303A2 Methods and compositions for treating age-related behavioral disorders in companion animals
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049769A2 Mutant herpes simplex viruses and uses thereof
11/08/2000EP1049717A2 Antibodies against human il-12
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049707A1 Ustilipides, method for the production and the use thereof
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049698A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049696A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/08/2000EP1049694A1 Benzothiadiazoles and derivatives
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049679A2 Sulphonamide derivatives for treatment of cns disorders
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049672A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049671A1 Azetidinecarboxamide derivatives for the treatment of cns disorders
11/08/2000EP1049670A1 Azetidinecarboxamide derivatives for treating cns disorders
11/08/2000EP1049479A1 Analgesic from snake venom
11/08/2000EP1049470A1 Extended release tiagabine formulations with reduced side-effects
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049462A1 Choline esters of fatty acids and their use in the treatment of stroke
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/08/2000EP0656002B1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
11/08/2000EP0637307B1 Imidazole, triazole and tetrazole derivatives
11/08/2000EP0588917B1 Isoxazole and isothiazole compounds that enhance cognitive function